These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 1915737)
1. Distribution and number of transferrin receptors in Parkinson's disease and in MPTP-treated mice. Mash DC; Pablo J; Buck BE; Sanchez-Ramos J; Weiner WJ Exp Neurol; 1991 Oct; 114(1):73-81. PubMed ID: 1915737 [TBL] [Abstract][Full Text] [Related]
2. Mesostriatal and mesolimbic dopamine uptake binding sites are reduced in Parkinson's disease and progressive supranuclear palsy: a quantitative autoradiographic study using [3H]mazindol. Chinaglia G; Alvarez FJ; Probst A; Palacios JM Neuroscience; 1992 Jul; 49(2):317-27. PubMed ID: 1436470 [TBL] [Abstract][Full Text] [Related]
3. Short- and long-term changes in striatal and extrastriatal dopamine uptake sites in the MPTP-treated common marmoset. Gnanalingham KK; Milkowski NA; Smith LA; Hunter AJ; Jenner P; Marsden CD Eur J Pharmacol; 1995 Apr; 277(2-3):235-41. PubMed ID: 7493614 [TBL] [Abstract][Full Text] [Related]
4. Autoradiographic localization and density of [125I]ferrotransferrin binding sites in the basal ganglia of control subjects, patients with Parkinson's disease and MPTP-lesioned monkeys. Faucheux BA; Herrero MT; Villares J; Levy R; Javoy-Agid F; Obeso JA; Hauw JJ; Agid Y; Hirsch EC Brain Res; 1995 Sep; 691(1-2):115-24. PubMed ID: 8590043 [TBL] [Abstract][Full Text] [Related]
5. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study. Gnanalingham KK; Smith LA; Hunter AJ; Jenner P; Marsden CD Synapse; 1993 Jun; 14(2):184-94. PubMed ID: 8332947 [TBL] [Abstract][Full Text] [Related]
7. Selective increase of NMDA-sensitive glutamate binding in the striatum of Parkinson's disease, Alzheimer's disease, and mixed Parkinson's disease/Alzheimer's disease patients: an autoradiographic study. Ułas J; Weihmuller FB; Brunner LC; Joyce JN; Marshall JF; Cotman CW J Neurosci; 1994 Nov; 14(11 Pt 1):6317-24. PubMed ID: 7965038 [TBL] [Abstract][Full Text] [Related]
8. Alterations in m-RNA expression for Cu,Zn-superoxide dismutase and glutathione peroxidase in the basal ganglia of MPTP-treated marmosets and patients with Parkinson's disease. Kunikowska G; Jenner P Brain Res; 2003 Apr; 968(2):206-18. PubMed ID: 12663090 [TBL] [Abstract][Full Text] [Related]
9. Alteration of neurotensin receptors in MPTP-treated mice. Tanji H; Araki T; Fujihara K; Nagasawa H; Itoyama Y Peptides; 1999; 20(7):803-7. PubMed ID: 10477079 [TBL] [Abstract][Full Text] [Related]
10. Regional and temporal expression of the peripheral benzodiazepine receptor in MPTP neurotoxicity. Kuhlmann AC; Guilarte TR Toxicol Sci; 1999 Mar; 48(1):107-16. PubMed ID: 10330690 [TBL] [Abstract][Full Text] [Related]
12. The role of striatopallidal neurones utilizing gamma-aminobutyric acid in the pathophysiology of MPTP-induced parkinsonism in the primate: evidence from [3H]flunitrazepam autoradiography. Robertson RG; Clarke CA; Boyce S; Sambrook MA; Crossman AR Brain Res; 1990 Oct; 531(1-2):95-104. PubMed ID: 2289139 [TBL] [Abstract][Full Text] [Related]
13. Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys. Goulet M; Morissette M; Grondin R; Falardeau P; Bédard PJ; Rostène W; Di Paolo T Synapse; 1999 Jun; 32(3):153-64. PubMed ID: 10340626 [TBL] [Abstract][Full Text] [Related]
14. Differential vulnerability of dopamine receptors in the mouse brain treated with MPTP. Tanji H; Araki T; Nagasawa H; Itoyama Y Brain Res; 1999 Apr; 824(2):224-31. PubMed ID: 10196452 [TBL] [Abstract][Full Text] [Related]
15. The dopamine transporter is absent in parkinsonian putamen and reduced in the caudate nucleus. Niznik HB; Fogel EF; Fassos FF; Seeman P J Neurochem; 1991 Jan; 56(1):192-8. PubMed ID: 1987318 [TBL] [Abstract][Full Text] [Related]
16. Expression of D(3) receptor messenger RNA and binding sites in monkey striatum and substantia nigra after nigrostriatal degeneration: effect of levodopa treatment. Quik M; Police S; He L; Di Monte DA; Langston JW Neuroscience; 2000; 98(2):263-73. PubMed ID: 10854757 [TBL] [Abstract][Full Text] [Related]
17. Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter. Calon F; Lavertu N; Lemieux AM; Morissette M; Goulet M; Grondin R; Blanchet PJ; Bédard PJ; Di Paolo T Synapse; 2001 Jun; 40(3):225-34. PubMed ID: 11304760 [TBL] [Abstract][Full Text] [Related]
18. Mitochondrial toxins in models of neurodegenerative diseases. II: Elevated zif268 transcription and independent temporal regulation of striatal D1 and D2 receptor mRNAs and D1 and D2 receptor-binding sites in C57BL/6 mice during MPTP treatment. Smith TS; Trimmer PA; Khan SM; Tinklepaugh DL; Bennett JP Brain Res; 1997 Aug; 765(2):189-97. PubMed ID: 9313891 [TBL] [Abstract][Full Text] [Related]
19. The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys. Rioux L; Frohna PA; Joyce JN; Schneider JS Mov Disord; 1997 Mar; 12(2):148-58. PubMed ID: 9087972 [TBL] [Abstract][Full Text] [Related]
20. Rapid and differential losses of in vivo dopamine transporter (DAT) and vesicular monoamine transporter (VMAT2) radioligand binding in MPTP-treated mice. Kilbourn MR; Kuszpit K; Sherman P Synapse; 2000 Mar; 35(4):250-5. PubMed ID: 10657034 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]